5 Key Takeaways

• 1

  Merck will acquire JSR Life Sciences’ chromatography business to enhance purification of therapeutic proteins by Q2 2026.

• 2

  Velaris has acquired Markes International to enhance its lab-automation capabilities in environmental and industrial analysis.

• 3

  Shimadzu plans to acquire Tescan for USD 678M to strengthen its electron microscopy offerings, with a closing expected in H1 2026.

• 4

  Thermo Fisher and NVIDIA are collaborating to integrate AI into lab processes, aiming for increased automation and accuracy.

• 5

  Agilent has launched the S540MD Slide Scanner System for high-throughput digital pathology, targeting European markets.